chain. Natural prostaglandins are laevorotatory and are characterized by a double bond on the alkyl side chain between C13 and CH and a hydroxyl group at C15 (Figure 2) . Several stereoisomeric forms of the molecule are possible. The majority of prostaglandins from natural sources have their side chains in the trans position (Nugteren et al. 1966) , that is, they are orientated on opposite sides of the ring. Prostaglandins in the cis form have both side chains on the same side of the ring. The degree of saturation and the type and position of radicles in the 5 carbon cyclopentane ring, determines the prostaglandin group. Prostaglandins A, B, E and F, are the four main naturally occurring groups (Figure 3 ). Prostaglandins A and B have a C9 keto group and a double bond in the ring, that of prostaglandin A being between CI0 and C11, and that of prostaglandin B being between C8 and C12. Prostaglandin E is characterized by a hydroxyl group at the C11 position and a keto group at C9. This keto group Bergstri:im et al. (1962a) reduced to a hydroxyl group, forming prostaglandin F.
Each of these basic groups has been subdivided. By fractionation, Bergstri:im et al. (1962b) subdivided prostaglandin E into three compounds (Figure 4 ). Prostaglandin El is stable and has a double bond on the alkyl side chain at C13 to CH. This is the position characteristic to the naturally occurring prostaglandins. Prostaglandin E2 has double bonds on the side chains at C13 to CH and C5 to C6, and prostaglandin Ea has an additional bond to these at C17 and Cl8. In other words, the degree of unsaturation of the side chains is indicated by a numerical suffix. When the C9 keto group on the cyclopentane ring is reduced to a hydroxyl group, prostaglandins Ft> F2 and Prostaglandin A is formed by alkalinizing prostaglandin E ( Figure 5 ). The group A compounds, originally known as prostaglandin E217, the number referring to the ultraviolet absorption maxima, are unstable and the double bond in the cyclopentane ring rearranges to form prostaglandin C and B compounds.
The prostaglandin C compounds have not been fully investigated. (Larsson and Anggard 1970) ; (3) in the rat liver ~ oxidation of the terminal carboxyl group with loss of carbon fragments occurs (Hamberg 1968), and (4) w oxidation has been demonstrated in the guinea pig liver (Israelsson, Hamberg and Samuelsson 1969) . Apart from the metabolites from the (313 reductase reaction, the metabolites of natural prostaglandins have less pharmacological activity than the parent compounds. Anaesthesia and Intensive Care, Vol. Ill, No. 2, j1,fay, 1975 The fate of exogenous prostaglandins varies according to their method of administration. The lungs and liver are chiefly responsible for the inactivation of circulating prostaglandins and may largely account for the absence of the hypotensive action of prostaglandin El injected into the portal vein (Nakano and Cole 1969) . If prostaglandin E is given intravenously to dogs, more than 95 per cent is removed by one passage through the lungs (Ferreira and Vane 1967) , probably by prostaglandin dehydrogenase (which has no action on some synthetic prostaglandins). For this reason, the hypotensive effect of prostaglandin E is maximal only when it is injected directly into the aorta (Carlson and Oro 1966) . Prostaglandin A is not metabolized in the lungs (McGiff et al. 1969) and its relatively slow clearance may be accounted for by its tighter chemical binding to human serum (Attallah and Schussler 1973) . Prostaglandin A, however, is an unstable molecule, and it has been suggested that some of the effects observed after its administration may be due to prostaglandin C (Horton 1972) .
When prostaglandins E2 and F 2 1)( are labelled by tritiated hydrogen and injected intravenously into humans, 50 per cent of prostaglandin E2 appears in the urine in five hours, and less than 3 per cent in the following 12 hours (Hamberg and Samuelsson 1969) . Tritiated prostaglandin F 2 1)( is excreted at a faster rate, 85 per cent to 95 per cent appearing in the urine after five hours (:;ranstrom and Samuelsson 1969).
While the administration of exogenous prostaglandins may be of value in studying the physiological and pharmacological effects on certain systems, understanding the role of endogenous prostaglandins is more difficult.
SYNTHESIS AND INHIBITION OF PROSTAGLANDINS
Although prostaglandins are present in almost all tissues in small amounts, it is not known what triggers their synthesis and release. Mechanical, endocrine and neural stimuli can be effective, and probably trigger a membrane bound enzyme system associated with the microsomal fraction of tissue homogenates (Lands, Lee and Smith 1971) . Inactivation by cytoplasmic dehydrogenase may take place within the cells in which they are formed. The mechanism by which the prostaglandins produce their physiological or pathological effects is not fully understood.
Their synthesis and activity can be inhibited in three ways ( Figure 7) ; (a) substrate inhibition is achieved by substituting essential fatty acid analogues such as tetraynoic acid for the precursor acid; (b) inhibition of prostaglandin synthesis by inactivating the enzyme prostaglandin synthetase with substances such as acetyl salicylic acid (Vane 1971) , indomethacin, paracetamol, phenylbutazone (Collier and Sweatman 1968) , dextropropoxyphene (Smith and Temple 1973), and perhaps morphine (Jaques 1969) ; and (c) by inhibiting prostaglandin activity with an agent such as polyphloretin phosphate which stabilizes the cell membrane (Beitch and Eakins 1969) .
STRUCTURE-ACTIVITY RELATIONSHIPS
The chemical structure of the naturally occurring prostaglandins can be related to their physiological activity. Wherever possible reference to the activity of the prostaglandins in humans or larger mammals has been made so that the relevance to man will not be obscured by variation in effect between species.
(a) Carboxyl Side Chain
Prostaglandin E, has a wide range of activity and is the compound against which other prostaglandins can be compared (Table 1) . The trans form of the molecule, with the two side chains on opposite sides of the ring, is the naturally occurring compound. In contrast, the cis form (e.g. 8 isoprostaglandin El) is less active, with diminished smooth muscle effects on the cardiovascular, gastrointestinal and reproductive systems, and a reduction in antilipolytic effect. However, the cis form shows no difference from prostaglandin E in its ability to inhibit platelet aggregation.
A double bond in the carboxyl side chain (e.g. prostaglandin E 2 ) has little effect on the vasodilating or smooth muscle stimUlating properties of prostaglandin E. 
Alterations in the arrangement of the radicles and in the saturation of the cyclopentane ring can markedly affect the properties of the prostaglandin groups. Prostaglandin E compounds which are characterized by a saturated ring and a CH keto group have maximal effects on gastric acid secretion and antilipolysis when compared with otber groups.
The prostaglandin F compounds have variable effects on the cardiovascular system ( Table 2 ). The Cl. form with the C9 hydroxyl group on tbe same side of the molecule as the carboxyl group is the stronger uterine stimulant and compares with prostaglandins El and E 2 . L'nlike the ~ (or epi) form with the Ul hydroxyl group on the opposite side to the carboxyl group it contracts bronchial smooth muscle.
Prostaglandins A and B are relatively inactive but when prostaglandin "~ is given intravenously it may appear to be more active than prostaglandin E because it is not metabolized in the lungs.
(c) Alflyl Side Chain
Alterations at the C13 position on the alkyl side chain can markedly affect the activity of the compound ( Table 3 ). The (J. form with the hydroxyl group on the same side of the molecule as the Cl carboxyl group is the naturally occurring structure. This is the structure of prostaglandin E and is called the S-orientation. The 
If the alkyl side chain length is reduced platelet aggregation is markedly inhibited and other effects are minimal. \\'hen the length of the chain IS increased, only antilipolytic properties remam.
SVSTE:llIC EFFECTS

Reproducti1'e System
Prostaglandins have been isolated from many sites in the reproductive system and they may Anaesthesia and IlItensive Care,
have a physiological role in reproduction. The richest natural source in humans is semen, but prostaglandins have also been isolated from endometrium, amniotic fluid (Karim 1966, Salmon and and umbilical cord (Karim 1967) . Labour has been induced with prostaglandins E2 and F 2 (X (Karim et al. 1968 , Karim and Sharma 1971 , Embrey 1970 , prostaglandin E2 being ten times as active as prostaglandin F 2 (X. A double blind clinical trial conducted by Beazley and Gillespie (1971) failed to demonstrate any difference between prostaglandins and oxytocics as uterine stimulants in labour. However, toxaemia and renal disease in pregnancy could be an indication for their use, because unlike oxytocics prostaglandins have no antidiuretic action. Prostaglandins appear to enhance the effect of oxytocics either by sensitizing the uterus or by an action on the pituitary.
Prostaglandins are effective in stimulating uterine activity where there is a foetal death in utero, and in the second trimester for termination of pregnancy (Roberts et al. 1972, and Mahendran 1972) and they may be therapeutically useful in these cases.
The mode of administration determines the incidence of side effects. Natural prostaglandins are poorly absorbed orally and if given by this route or parenterally in the large doses required for abortion, there may be a high incidence of nausea and vomiting (Barr and Naismith 1972). Other side effects include fever, dysmenorrhoea following abortions, asthma, glaucoma and a local phlebitis. Hypotension has not occurred in the doses used for abortion and blood coagulation changes have shown no significant difference from those occurring physiologically (Badraoui et al. 1973a , Badraoui et al. 1973b ).
Gastrointestinal System
Prostaglandins El and A increase gastric motility, decrease the gastric secretory response, decrease gastric mucosal blood flow and increase the intestinal propulsive activity, probably by reducing absorption (WaIler 1973). The electrolyte content of jejunal fluid secreted in response to prostaglandins is similar to that produced by cholera endotoxin and both appear to increase the gut adenyl cyclase activity (Sharp and Hynie 1971, Kimberg et al. 1971) . Some patients with medullary carcinoma of the thyroid have diarrhoea which is associated with an increase in prostaglandin E2 (Williams, Karim and Sandler 1968) . Prostaglandins, by reducing intestinal absorption, may be the cause of this diarrhoea.
The inhibiting effect on gastric acid secretion by prostaglandins might provide a therapy against peptic ulcer formation, for this, synthetic prostaglandins need to be developed which are effective orally, have a longer duration and greater selectivity in action. Oral prostaglandin E is not absorbed from the gastrointestinal tract, but a synthetic form, 15 methyl E2 methyl ester in its R form (the S form having an unphysiological uterine stimulant effect), is effective when given orally and has been investigated by Karim et al. (1973) and Amy et al. (1973) . The result of 100 [Lg nasogastrically at two-hourly intervals indicated that inhibition of gastric acid secretion was maximal 90 minutes after administration, but after a few hours tachyphylaxis occurred. The volume of the aspirate was not significantly reduced. This antacid effect may be beneficial when prostaglandins are used as uterine stimulants in labour, to avoid acid aspiration.
Cardiovascular System
The hypotensive effect of prostaglandins observed by von Euler (1937) was mainly due to the effects of prostaglandins E and A which produced vasodilatation and reduced the systemic vascular resistance.
They have recently been used clinically as antihypertensive agents (Christlieb et al. 1969 ) but oral administration has proved unacceptable because of the high incidence of side effects. After parenteral administration their antihypertensive action is short and rebound hypertension may occur. Considerable individual variation in the hypotensive response occurs, but these prostaglandins may be of use in renoprival hypertension, i.e. following nephrectomy or a salt load. In contrast with prostaglandins E and A, the effect of prostaglandin F is variable, and in doses given therapeutically to humans, no significant alteration in blood pressure has been observed although it has a pressor effect in dogs (Nakano and Cole 1969) .
Prostaglandins E and F have positive inotropic actions which occur in isolated preparations and are associated with increased adenyl cyclase activity (Sobel and Robinson 1969) . Prostaglandin El can restore normal function to a myocardium which has received an overdose of potassium (Vergroesen and DeBoer 1968) . The effect of potassium appears to be antagonized rather than the effect of calcium being enhanced.
In animals a species difference may account for both positive and negative chronotropic responses to prostaglandin El> but in humans there is definite chronotropism (Bergstrom et al. 1959b ). This may be an indirect effect of prostaglandins increasing sympathetic stimulation.
When the foetal ductus was rendered anoxic, prostaglandins El and E2 markedly relaxed the vessel but had little action on the ductus when it was exposed to oxygen (Coceani and Olley 1973) . This effect suggests a role for prostaglandins in regulating vessel tone during foetal life.
Respiratory System
The effects of prostaglandins on this system may be important in anaesthetic practice. Prostaglandin F 2(1. is present in human lung tissue and contracts bronchial smooth muscle in vivo and in vitro (Sweatman and Collier 1968) . Prostaglandin E is a bronchodilator, but there has been difficulty in making a non-irritant aerosol with it. Intravenous prostaglandin E does not appear to have an advantage over isoprenaline but inhaled prostaglandin El may avoid the cardiovascular disturbances which occur after overdosage from isoprenaline aerosols (Large, Leswell and l\Iaxwell 1969, Cuthbert 1969) .
The role in asthma of prostaglandin E2 deficiency or prostaglandin F 2 (1. increase is debatable (Cuthbert 1971) . Asthmatics are much more sensitive than normal subjects to prostaglandin F 2 (1. (Fishburn et al. 1972 , MatM et al. 1973 . However, the response to acetyl salicylic acid, phenylbutazone and indomethacin in asthmatics is variable. l\Iathe, Strandberg and Astrom (1971) have shown that polyphloretin phosphate blocks prostaglandin F 2 (1. induced contraction of bronchial muscle leaving the relaxant effect of prostaglandin E2 unaffected. This difference in action between prostaglandins E2 and F 2 (1. could possibly be of use in the treatment of asthma.
A number of diverse stimuli release prostaglandins from the isolated perfused lungs of the guinea pig (Piper and Vane 1971) . These include air emboli and intermittent positive pressure ventilation (Edmonds, Berry and Wyllie 1969) . Piper and Vane (1971) suggest that the release of prostaglandins may follow any disturbance of the cell membrane, and that they may affect not only bronchial smooth muscle but also the pulmonary vasculature.
Renal System
Prostaglandins E 2 , A2 and F 2(1. can be extracted from the renal medulla but not from the cortex. Prostaglandin:; E2 and A2 reduce renal vascular resistance while F 2 (1. increases it (Horton 1969) . Renal vasodilatation will minimize the effect of hypotension on renal blood flow so that renal function is not compromised. This is an effect which might be of advantage in hypotensive anaesthesia.
Prostaglandins E and A can cause a naturesis and diuresis if no hypotension develops, presumably by vasopressin antagonism, and this may be beneficial in certain obstetric patients.
Ophthalmology
Prostaglandins in ophthalmology demonstrate the relation between themselves and the inflammatory reaction.
Raised levels of prostaglandin-like substances are an important feature of acute anterior uveitis (Eakins et al. 1972) . Polyphloretin phosphate, indomethacin and acetyl salicylic acid can reduce this inflammatory reaction (Sears, Neufeld and Jampol 1973) . Only prostaglandin E2 has been extracted from the non-diseased eye but in inflammation, rabbits' eyes contain prostaglandin El' In uveitis there are a large number of white blood cells in the anterior chamber and since the intact rabbit polymorph can release prostaglandin E it is postulated that prostaglandin El produces the pathological changes. The role of white blood cells in other parts of the body in releasing prostaglandin El' and the effect of prostaglandins on the inflammatory process are speculative.
lYervozls System
Prostaglandins E and F occur in nervous tissue (Holmes and Horton 1967) and can affect both the central and peripheral nervous system. Their central actions include a febrile reaction, meningeal irritation with headache, catatonia, sedation and anticonvulsant activity when given intraventricularly (Horton and Main 1967) . Prostaglandins cross the blood brain barrier poorly and tachyphylaxis is common with parenteral administration. The role for prostaglandins in the central nervous system is uncertain; they may be physiological transmitters or have a pathological role in inflammation.
Peripherally, prostaglandins have been thought to sensitize pain receptors, since slow intradermal injection of prostaglandins has produced hyperalgesia (Ferreira 1972) and histamine itching becomes greatly magnified when prostaglandins are administered (Greaves and McDonald-Gibson 1973) . Prostaglandins also have an effect on adrenergic nerve endings. Their precise mode of action is unknown, but there appears to be a presynaptic control to reduce the amount of noradrenaline released in response to nerve stimulation (Horton 1973) .
Prostaglandins act on the sympathetic nervous system in another manner.
Lipolysis is stimulated by a number of hormones including noradrenaline, which act on adenyl cyclase (Figure 8 ). Prostaglandins inhibit lipolysis (Bergstrom, Carlson and Oro 1964c) either by inhibiting adenyl cyclase, or by reducing the ions available for activating cyclic AMP (which activates the enzyme, lipase) or by stimulating the breakdown of cyclic AMP. Apart from their effect on lipolysis, prostaglandins may regulate the cyclic AMP mediated actions of various hormones or drugs at target organs. This action of prostaglandins on cyclic AMP appears to be a strategic part of the metabolic control system of the body and a disorder of this may be the primary aetiology of certain diseases.
SYNTHESIS AND ADMINISTRATION
Prostaglandins were originally prepared by biosynthesis using enzyme extracts from sheep vesicular glands and fatty acid substrates, but this yielded only limited quantities. Direct extraction from tissues rich in prostaglandins, e.g. Plexaura homomalla (a form of coral), can yield large quantities. Total chemical synthesis is now the method of choice, because synthetic forms which are not found naturally, can now be manufactured. These may prove more specific and stable, and have fewer side effects than the naturally occurring prostaglandins. Prostaglandin E2 is available in two forms.
For oral administration it is dissolved in the solvent dimethylacetamide which reacts with plastic. The compound is fairly stable and can be kept for two years at 18° C. This is unlike the intravenous preparation in alcohol which requires refrigeration at less than 4°C and under these conditions remains potent for only one year. Both solutions should be diluted before use and then discarded after twenty-four hours storage.
Prostaglandin F 2 ry; is more stable and is insensitive to light, heat and alkali. It has a shelf life of 24 months and is soluble in water. Prostaglandins E2 and F 2 ry; are currently used for the induction of labour and the termination of pregnancy. The use of prostaglandins as antihypertensives, bronchodilators, nasal decongestants, antacids, diuretics and antithrombotic agents has not been fully explored. CONCLUSION The development of industrial processes for the supply of prostaglandins should lead to a greater understanding of both the physiology and pharmacology of these substances. Although they appear to be synthesized in the membrane of every cell in the body their exact role in normal homeostasis has not yet been fully determined. The fact that prostaglandins can be extracted from a tissue does not necessarily mean that they have a physiological role in that tissue, and many tissues when stimulated release more prostaglandins than they contain.
Certainly, prostaglandins are highly potent even in minute amounts and their pharmacological actions are both numerous and varied. Their side effects, when used in obstetrics, on the lungs, the gastro-intestinal tract and the kidney are of importance to anaesthetists, and their cardiovascular activity, e.g. induction of hypotension and positive inotropism may be used therapeutically. One hopes that prostaglandin analogues may be found which are more potent and specific and that antagonists to their unwanted actions may also be developed.
